1Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflamation and cardiovascular disease [ J ].Circulation,2003,107:499-511.
2Ridker PM.High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention [J]. Am J Cardiol, 2003,92:17-22.
3MaUat Z, Henry P, Fressonnet R, et al .Increased plasma concentrations of interleukinl 8 in acute coronary syndromes [J].Heart,2002,88: 467-469.
4Mallat Z, Corbaz A, Scoazec A, et al. lnterleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability[J]. Circ Res, 2001,89: 41-45.
7Biasucci LM, Liuzzo G, Giubilato S,et al. Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability[J]. Eur Heart J, 2009,30:2220-2225.
8Kawasaki D, Tsujino T, Morimoto S, et al. Plasma interleukin-18 concentration: a novel marker of myocardial isehemia rather than necrosis in humans[J]. Coron Artery Dis, 2005,16:437--441.
9Kai H, Jkeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteinase-2 and -9 are elevated in patients with acute coronary syndromes[J]. Am colt cardioal, 1998,32:368-372.
10Ahsan CH, Shah A, Ezekowitz M. Acute statin treatment in reducing risk after acute coronary syndrome:the MIRACL trial [J]. Curr Opin Cardio, 2001,16:390-393.
4[2]Massberg S,Brand K,Gruner S,et al.A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.Exp Med,2002,196:887-896.
5[3]Boring L,Gosling J,Cleary M,et al.Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.Nature,1998,394:894 -897.
7Ridker PM, Morrow D. High-sensitivity C-reaction protein and cardio- vascular risk:rationale for screening and primary prevention [ J ]. Am J Cardiol, 2003,92 ( Suppl ) : 17 -22.
8Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) Randomized Trial [J].J Am Coil Cardiol, 2009, 54(6) : 558-565.
9Ltiftjohann D, Sigit I J, Locatelli S, et al. High-dose simvastatin( 80 rag/ day)decreases plasma concentrations of total bomocysteine in patients with hypercholesterolemia [ J 1. Atherosclerosis , 2001,155 ( 1 ) : 265- 266.
10Macin SM, Pema ER, Farias EF, et al. Atorvastatin has an important acu{e anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study [ J ]. Am Heart ,2005,149(3 ) :451-457.
